Evidence map›Paper›PMID 36980476›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms.

Shuwei Weng, Die Hu, Jin Chen, Yanyi Yang, Daoquan Peng

Open access · goldFull text read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shuwei WengDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Die HuDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Jin ChenDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Yanyi YangHealth Management Center, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Daoquan PengDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

National Natural Science Foundation of China 81870336
6 · The paper itself

Abstract

backgroundFatty liver disease (FLD) is an important risk factor for liver cancer and cardiovascular disease and can lead to significant social and economic burden. However, there is currently no nationwide epidemiological survey for FLD in China, making early FLD screening crucial for the Chinese population. Unfortunately, liver biopsy and abdominal ultrasound, the preferred methods for FLD diagnosis, are not practical for primary medical institutions. Therefore, the aim of this study was to develop machine learning (ML) models for screening individuals at high risk of FLD, and to provide a new perspective on early FLD diagnosis.

methodsThis study included a total of 30,574 individuals between the ages of 18 and 70 who completed abdominal ultrasound and the related clinical examinations. Among them, 3474 individuals were diagnosed with FLD by abdominal ultrasound. We used 11 indicators to build eight classification models to predict FLD. The model prediction ability was evaluated by the area under the curve, sensitivity, specificity, positive predictive value, negative predictive value, and kappa value. Feature importance analysis was assessed by Shapley value or root mean square error loss after permutations.

resultsAmong the eight ML models, the prediction accuracy of the extreme gradient boosting (XGBoost) model was highest at 89.77%. By feature importance analysis, we found that the body mass index, triglyceride, and alanine aminotransferase play important roles in FLD prediction.

conclusionXGBoost improves the efficiency and cost of large-scale FLD screening.

Indexed as

early screeningfatty liver diseasemachine learningXGBoost

Identifiers

PMID36980476
PMCPMC10047083
OpenAlexW4327972571

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read18
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.